Investigative Ophthalmology & Visual Science Cover Image for Volume 59, Issue 9
July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The effect of Anti-CD80/86 antibody on regulatory T cells in murine corneal transplantation.
Author Affiliations & Notes
  • Keiichi Fujimoto
    Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan
  • Takenori Inomata
    Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan
  • Koichiro Uchida
    Atopy Research Center , Tokyo, Japan
  • Yuichi Okumura
    Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan
  • Akira Murakami
    Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Keiichi Fujimoto, None; Takenori Inomata, None; Koichiro Uchida, None; Yuichi Okumura, None; Akira Murakami, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3307. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Keiichi Fujimoto, Takenori Inomata, Koichiro Uchida, Yuichi Okumura, Akira Murakami; The effect of Anti-CD80/86 antibody on regulatory T cells in murine corneal transplantation.. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3307.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the effect of anti-CD80/86 antibody on CD4+CD25+Foxp3+ regulatory T cells (Tregs) at ipsilateral draining lymph nodes (dLNs) in murine corneal transplantation.

Methods : Corneal grafts from C57BL6 mice were transplanted to BALB/c mice. Anti-CD80/86 (50 μg) was administered to transplanted mice by intraperitoneal injection (i.p.) every 24 hours post transplantation for 3 days (IP3 group), 5 days (IP5 group) or 7 days (IP7 group); PBS was administered as control. dLNs were harvested 7 days after transplantation and analyzed for Tregs, CD11c+ MHC class II + dendritic cells (mDC) by flow cytometry. The expression level of Foxp3, CTLA-4 in Tregs and MHC2 in dendritic cells were analyzed by mean fluorescence intensity (MFI) using flow cytometry.

Results : There were no significant differences between the frequencies of CD4+ cells among groups. Anti-CD80/86 administration reduced the frequencies of Tregs compared to control (control:13.3%, IP3:8.8%, IP5:7.8%, IP7:8.0%, p<0.0001). After anti-CD80/86 administration, there was an increase in MFI expression of CTLA-4 in dLN compared to control, but no differences were noted for Foxp3 (Foxp3; control:10401, IP3:11171, IP5:9856, IP7:9478, p<0.07, CTLA-4; control: 3723, IP3: 2359, IP5: 2050, IP7: 1996, p<0.001). There were no differences in frequencies of mDC and the MFI expression of MHC class II after anti-CD80/86 administration.

Conclusions : Anti-CD80/86 administration for more than 3 days causes differentiation failure of Tregs in dLNs.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×